We included in our analysis tumor antigens MUC1 and HER2, which have been reported to be over-expressed in breast cancer and to affect macrophage function (19, 23), and the “eat-me” signal CRT and the “don’t eat me” signal CD47 (24). Here, ERBB2 is linked to breast carcinoma.